FDA Import Refusal AEK-7431732-9/11/1 — Merck, Inc.

Merck, Inc. — FEI 2210048

The FDA refused shipment AEK-7431732-9/11/1 from Merck, Inc. (United States) on Jun 5, 2020. The refused product falls under Drugs and Biologics — SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.